Aptorum Group Ltd. operates as a pre-clinical early stage biotech company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. Read More The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; operates the activities of AML Clinic; and sale of dietary supplement. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.